Atlas Trials

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Clinical trial NCT03539731 · TERMINATED

Trial details

NCT number
NCT03539731
Sponsor
Guido A. Davidzon, MD, SM
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy SubjectIntracranial NeoplasmGlioblastoma
Start date
2018-04-23
Primary completion
2022-12-31
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.